Can rapid on-site pathogen detection change the economics of food safety in North America?

Hardy Diagnostics has entered into a strategic distribution agreement with NEMIS Technologies to bring the Swiss company’s N-Light chemiluminescence pathogen detection platform to the North American market. The move positions Hardy Diagnostics to capture a larger share of the food safety and environmental monitoring market by integrating rapid, on-site microbiological testing capabilities.

The collaboration comes amid mounting regulatory and supply chain pressure on food producers to improve contamination control and response times. For NEMIS Technologies, the partnership provides a commercialization foothold in the United States and Canada without the overhead of direct market entry, while Hardy Diagnostics bolsters its reputation as a microbiology innovator beyond its traditional lab media offerings.

Why is this partnership a strategic step forward for on-site testing and HACCP 2.0 in the food industry?

The partnership’s central value proposition lies in accelerating pathogen detection timelines in operational environments where even a few hours of delay can trigger costly product recalls or plant shutdowns. Hardy Diagnostics will serve as the exclusive North American partner for NEMIS Technologies, enabling rollout of the N-Light detection system across food manufacturing, processing, and packaging facilities.

Unlike conventional laboratory-based assays, which often require sample transport, enrichment, and overnight culturing, NEMIS Technologies’ platform enables pathogen detection to occur directly on-site using a simple swab-to-result format. The core technology relies on a proprietary chemiluminescent reaction that emits visible light when target bacteria are present. Initial applications target Listeria monocytogenes, Salmonella, and Escherichia coli, among others.

The operational shift this enables—moving testing from centralized labs to factory floors—marks a fundamental evolution in the implementation of Hazard Analysis and Critical Control Points (HACCP) protocols, often referred to as “HACCP 2.0.” As manufacturers increasingly aim for real-time hygiene surveillance and rapid root-cause analysis during contamination events, demand is growing for high-fidelity diagnostics that can operate outside controlled lab settings.

By aligning with this trend, Hardy Diagnostics is effectively expanding its addressable market from diagnostic laboratories to active production lines, including meat, dairy, seafood, retail-ready, and high-throughput food preparation facilities.

How does the N-Light platform compare to incumbent technologies in food safety diagnostics?

Most conventional pathogen testing platforms used in food manufacturing rely on molecular techniques such as polymerase chain reaction (PCR), immunoassays, or culture enrichment. While accurate, these systems often require specialized personnel, high-maintenance equipment, and time-consuming workflows. Some newer solutions have added partial automation, but few offer truly on-site execution with minimal training.

The NEMIS Technologies N-Light system circumvents many of these limitations. Its self-contained swab test uses pre-loaded reagents and does not require advanced instrumentation, cold-chain storage, or offsite processing. Results are typically available within 24 hours, offering a balance between sensitivity and operational feasibility.

Critically, the N-Light system’s luminescent output reduces ambiguity in interpreting results, minimizing false negatives and user error. It also requires minimal training, which suits high-churn environments such as contract manufacturing sites, quick-service food suppliers, and seasonal production plants. These characteristics make it attractive not just to large industrial players but to small and medium-sized processors under pressure to meet evolving safety standards.

What makes Hardy Diagnostics the right commercialization partner for NEMIS Technologies in the United States?

Hardy Diagnostics has built its reputation as a specialist in diagnostic culture media and microbiological testing tools, particularly for clinical and laboratory settings. However, the company has increasingly diversified into food safety, water testing, and industrial hygiene segments over the past decade.

With distribution infrastructure spanning the continental United States, Hardy Diagnostics brings more than logistical reach—it offers regulatory familiarity, customer access, and technical support capabilities that are essential for scaling a precision diagnostic system in a highly fragmented industry.

The company’s existing footprint among quality assurance professionals, food safety officers, and environmental hygiene managers gives it privileged access to decision-makers at food production facilities. Furthermore, its U.S. base enables smoother coordination with FDA, USDA, and CDC frameworks—especially as food safety modernization acts prioritize traceability and preventive control.

This partnership also includes educational infrastructure in the form of NEMIS Academy, a training initiative that will likely run in conjunction with Hardy Diagnostics’ technical services division. By building knowledge alongside deployment, the two companies aim to mitigate the adoption curve—a known challenge in the notoriously conservative food manufacturing sector.

How might this reshape the competitive landscape of food microbiology testing in North America?

The market for food pathogen testing in North America is estimated to be worth over $5 billion annually, driven by regulatory mandates, brand risk aversion, and growing consumer scrutiny. Major incumbents include Thermo Fisher Scientific, bioMérieux, Neogen Corporation, Hygiena (a subsidiary of Warburg Pincus-backed Cantel Medical), and 3M’s food safety unit (recently acquired by Neogen).

These firms largely rely on centralized testing labs or sell kits designed for offsite use. The NEMIS–Hardy partnership positions itself differently—not as a competitor to gold-standard lab protocols, but as a rapid decision-support tool that enables earlier intervention in production environments.

That may prove strategically disruptive. For instance, in perishable segments like seafood or fresh produce, shortening the time-to-result could prevent entire batches from being discarded based on delayed lab results. In sectors where shelf life is measured in days, time saved is inventory saved.

Moreover, as ESG-driven metrics and safety transparency continue to shape procurement policies—especially from large retailers and foodservice groups—being able to demonstrate proactive, real-time hygiene monitoring may soon become a competitive differentiator.

This “last-mile” testing model could also push competitors to expand their point-of-use offerings or acquire platforms with field-deployable diagnostics. The ability to provide integrated lab-to-line solutions may become the next battleground in food microbiology.

What are the broader implications for sustainability, regulation, and supply chain resilience?

From a sustainability standpoint, reducing false positives and enabling faster clearance of food production lines can lower water usage, energy consumption, and product waste. These operational efficiencies support corporate climate goals, particularly in sectors under increasing pressure to demonstrate Scope 3 emissions reductions and sustainable production practices.

From a regulatory angle, on-site testing fits into a broader FDA and USDA pivot toward risk-based oversight and traceability. Platforms like N-Light could eventually be embedded into compliance documentation workflows, digitized audit trails, and real-time plant performance metrics shared with oversight agencies.

On the supply chain side, faster testing reduces cold-chain dwell time and unlocks more dynamic fulfillment models, which is especially valuable for retailers and foodservice providers seeking agility.

If Hardy Diagnostics and NEMIS Technologies succeed in scaling adoption, they may contribute to a wider industry shift toward localized, predictive, and proactive food safety ecosystems—effectively closing the gap between contamination event and corrective action.

What are the key takeaways from Hardy Diagnostics’ partnership with NEMIS Technologies?

• Hardy Diagnostics will exclusively distribute NEMIS Technologies’ rapid N-Light pathogen detection system across North America, targeting food safety applications.

• The collaboration enables real-time, on-site testing for pathogens like Listeria, Salmonella, and E. coli in food manufacturing and environmental hygiene settings.

• N-Light uses chemiluminescence to deliver easy-to-interpret results without advanced equipment or lab processing, reducing time to decision.

• Hardy Diagnostics gains a significant competitive edge by expanding into field-based diagnostics beyond its traditional lab media offerings.

• The partnership supports HACCP 2.0 practices by embedding proactive hygiene monitoring directly onto production floors.

• Incumbent food testing providers may face pressure to offer similar point-of-use or faster testing solutions to remain competitive.

• The alliance reflects a broader trend toward decentralizing pathogen detection to support ESG, regulatory, and operational resilience goals.

• Educational components like the NEMIS Academy aim to lower adoption barriers and accelerate skill development across food safety teams.